Drawing for SINGLE-CELL PRINTER

USPTO serial 79223163

SINGLE-CELL PRINTER

Reviewed by CopyMark Law Group

Reg. 5784063Status 709
Filing date
Status date
Registration date
Jun 25, 2019
Examiner
GLASSER, CARYN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with SINGLE-CELL PRINTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Mark T. Vogelbacker

Mark T. Vogelbacker Eckert Seamans Cherin & Mellot, LLC50 S. 16th Street, 22nd FloorPHILADELPHIA, PA 19102-2516United States

Goods and services

ClassDescriptionStatusFirst use
009Laboratory apparatus and instruments, namely, laboratory apparatus and instruments for the processing and investigation of particles; laboratory apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of particles; laboratory apparatus and instruments for the handling and culture of cells; laboratory apparatus and instruments for the processing and investigation of cells; laboratory apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of cells; laboratory apparatus and instruments for generating and detecting fluorescent or luminescent signals associated with particles and/or cells, for the imaging, identification, isolation, separation, dispensing and deposition of particles and/or cells; laboratory apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of cells for genetic or biochemical analysis; laboratory apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of animal, plant, insect, fungal or human cells, and/or of bacterial cells; scientific research and laboratory apparatus, namely, scientific research and laboratory apparatus for the processing and investigation of cells or other particles, scientific research and laboratory apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of cells or other particles, with such scientific research and laboratory apparatus generating and detecting fluorescent or luminescent signals associated with such cells or other particles, and such scientific research and laboratory apparatus for genetic or biochemical analysis of cells, and such scientific research and laboratory apparatus for animal, plant, insect, fungal or human cells, and bacterial cells; any of the aforesaid goods for individual or single cells or other particlesSECTION 71 - CANCELLED—
010Medical apparatus and instruments for the imaging, identification, isolation, separation dispensing and deposition of cells, namely, sample separation and cell dispensing devices providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; medical apparatus and instruments for the imaging, identification, isolation, separation, dispensing and deposition of cells for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing with all the aforesaid goods for individual or single cellsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 9, 2026INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jan 9, 2026C71TCANCELLED SECTION 71—
May 16, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 25, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 23, 2023EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Oct 23, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 23, 2023ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Oct 23, 2023ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 23, 2023REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 18, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
May 8, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 6, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 18, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 29, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 29, 2019FIMPFINAL DISPOSITION PROCESSED—
Sep 25, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2019ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jun 25, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 9, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 9, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 5, 2019GPNXNOTIFICATION PROCESSED BY IB—
Mar 20, 2019OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 20, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 20, 2019OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 18, 2018PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Aug 27, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Aug 27, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 27, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 27, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Jul 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 23, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 23, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 2, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 20, 2018CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
May 25, 2018CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Feb 16, 2018RFNTREFUSAL PROCESSED BY IB—
Jan 23, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 23, 2018RFRRREFUSAL PROCESSED BY MPU—
Jan 13, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 12, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 4, 2018DOCKASSIGNED TO EXAMINER—
Dec 22, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Dec 18, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2017LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Dec 14, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance